Reply

Arun J Sanyal¹, Chuhan Chung², Robert P Myers², Jaime Bosch^{3

4}

Affiliations

¹ Virginia Commonwealth University, Richmond, Virginia, USA.
² Gilead Sciences, Inc., Foster City, California, USA.
³ Hospital Clinic-IDIBAPS and Ciberhed, University of Barcelona, Barcelona, Spain.
⁴ Department of Visceral Surgery and Medicine, Bern University, Bern, Switzerland.

Arun J Sanyal et al. Hepatology. 2022 Jul.

. 2022 Jul;76(1):E5-E6.

doi: 10.1002/hep.32373. Epub 2022 Apr 18.

Arun J Sanyal¹, Chuhan Chung², Robert P Myers², Jaime Bosch^{3

4}

¹ Virginia Commonwealth University, Richmond, Virginia, USA.
² Gilead Sciences, Inc., Foster City, California, USA.
³ Hospital Clinic-IDIBAPS and Ciberhed, University of Barcelona, Barcelona, Spain.
⁴ Department of Visceral Surgery and Medicine, Bern University, Bern, Switzerland.

No abstract available

References

1. Sanyal AJ, Anstee QM, Trauner M, Lawitz EJ, Abdelmalek MF, Ding D, et al. Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis. Hepatology. 2022;75:1235-46.
1. Lassailly G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, Baud G, Verkindt H, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159:1290-301.e5.
1. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367-78.e5; quiz, e14-e15.
1. Bosch J, Harrison SA, Ratziu V, Anstee QM, Trauner M, Lawitz EJ, et al. Impact of modest weight reduction on serum markers, liver histology, and disease progression in patients with advanced fibrosus due to nonalcoholic steatohepatitis (NASH). Presented at The Liver Meeting 2021 of the American Association for the Study of Liver Diseases [Oral Presentation 2156]. Hepatology. 2021;74(Suppl.):155A-6A.